ZSAN Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 Dec 1970 @ 19:00):

Stats
Today's Volume	1.16M
Average Volume	5.36M
Market Cap	0.00
EPS	$-1.760 ( 2022-05-13 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.936
ATR14	$0.221 (39.63%)

Insider Trading

Date	Person	Action	Amount	type
2022-06-06	Matthews Christine	Sell	82	Common Stock
2022-06-06	Lo Steven	Sell	442	Common Stock
2022-03-31	Matthews Christine	Sell	8 116	Common Stock
2022-03-31	Kellerman Donald J	Sell	4 006	Common Stock
2022-03-31	Lo Steven	Sell	23 633	Common Stock

INSIDER POWER
-100.00
Last 98 transactions
Buy: 6 809 170 \| Sell: 191 091

Volume Correlation

Long: -0.45 (neutral)

Short: 0.20 (neutral)

Signal:(26.225) Neutral

Zosano Pharma Corp Correlation

10 Most Positive Correlations
ARQQ	0.958
QTEK	0.957
AVO	0.954
QLGN	0.948
FATE	0.945
FNCH	0.941
IMCC	0.941
NKTX	0.941
CFBK	0.94
BNOX	0.939

10 Most Negative Correlations
DVCR	-0.974
OPNT	-0.957
EWEB	-0.951
LMNX	-0.951
AVEO	-0.947
STAY	-0.946
HZNP	-0.943
LUNA	-0.943
NWFL	-0.941
AVAC	-0.94

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zosano Pharma Corp Correlation - Currency/Commodity

0.59
( weak )

0.49
( neutral )

0.34
( neutral )

-0.77
( moderate negative )

-0.65
( moderate negative )

Zosano Pharma Corp Financials

Annual	2021
Revenue:	$785 000
Gross Profit:	$-11 000.00 (-1.40 %)
EPS:	$-0.270

Q1	2022
Revenue:	$132 000
Gross Profit:	$46 000.00 (34.85 %)
EPS:	$-7.88

Q4	2021
Revenue:	$87 000.00
Gross Profit:	$-5 000.00 (-5.75 %)
EPS:	$-0.0600

Q3	2021
Revenue:	$252 000
Gross Profit:	$-88 000.00 (-34.92 %)
EPS:	$-0.0700

Financial Reports:

No articles found.

Zosano Pharma Corp

Zosano Pharma Corporation, a clinical stage biopharmaceutical company, focuses on providing therapeutics and other bioactive molecules to patients suffering from migraine using its transdermal microneedle system. Its lead product candidate is Qtrypta (M207), a proprietary formulation of zolmitriptan used for the acute treatment of migraine. The company was founded in 2006 and is headquartered in Fremont, California. On June 1, 2022, Zosano Pharma Corporation filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.